Clinical Trial Update: Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial by UMC Utrecht evaluating lenalidomide, cyclophosphamide, and prednisone in multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Endoxan (Cyclophosphamide)
• Prednison (prednisone)
• Revlimid (lenalidomide)

Snippet

Sponsor: UMC Utrecht | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED